micro-community-banner
  • Saved

3mo
Transvenous Coronary Sinus Lead Placement in Systemic Right Ventricle With D-TGA and Atrial Baffle - PubMed

Transvenous Coronary Sinus Lead Placement in Systemic Right Ventricle With D-TGA and Atrial Baffle - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41342803/

Imaging in the setting of D-TGA patients with right ventricular dysfunction may identify accessible coronary sinus anatomy, eliminating the need for repeat sternotomy while providing cardiac resynchronization therapy benefits.

Imaging-guided transvenous coronary sinus lead placement successfully provided CRT in a D-TGA patient with systemic RV failure, avoiding repeat sternotomy and improving function—demonstrating a novel, less invasive strategy.

  • Saved

4mo
Surgical treatment of a giant cardiac hemangioma in right atrium with pulmonary vein compression - PubMed

Surgical treatment of a giant cardiac hemangioma in right atrium with pulmonary vein compression - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41250155/

Although rare, cardiac hemangiomas should be considered in the differential diagnosis of intracardiac masses. Complete surgical resection is feasible and leads to favorable outcomes, even in cases with complex anatomical...

Asymptomatic man had a rare large right atrial cavernous hemangioma compressing the pulmonary vein; PET-CT identified the mass, complete surgical resection was successful, and postoperative recovery was excellent.

  • Saved

4mo
AHA Scientific Sessions 2025: Transformative advances in cardiovascular care

Dr. Joanna Chikwui, Chief of Cardiac Surgery at Cedars-Sinai and Chair of AHA Scientific Sessions, spotlighted significant breakthroughs across cardiology. Updates included novel therapies for hyperlipidemia, gene-editing tools for inherited cardiovascular risk, innovations in atrial fibrillation management, and compelling lifestyle findings—including a surprising inverse relationship between moderate coffee intake and AF incidence.

Dr. Heidi May, Epidemiologist at Intermountain Health, presented results from the Target-D randomized trial, which found that personalized vitamin D dosing after myocardial infarction significantly reduced the risk of recurrent heart attack. These findings underscore the importance of individualized supplementation strategies and signal a broader shift toward precision prevention and risk stratification in cardiovascular care.

Share your thoughts

  • Saved

4mo
Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis - PubMed

Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41261111/

Cardiovascular diseases and diabetes are associated with significant mortality, morbidity, and economic burden, highlighting the need for alternative preventive strategies. Honey bee products, including honey, royal jelly, and propolis, are...

Review of 69 RCTs shows honey has mixed metabolic effects, while royal jelly and propolis provide dose-dependent improvements in lipids, glycemic control, inflammation, and oxidative stress, supporting their potential cardiometabolic benefits with cautious honey use.

  • Saved

4mo
Optional or optimal? off-label stenting for intracranial atherosclerotic stenosis: A scoping review - PubMed

Optional or optimal? off-label stenting for intracranial atherosclerotic stenosis: A scoping review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37122266/

BackgroundIntracranial atherosclerotic stenosis is a major cause of ischemic stroke. In addition to the Wingspan stent system, several self-expanding stents have been used off-label to treat intracranial atherosclerotic stenosis lesions....

Off-label self-expanding stents for intracranial atherosclerotic stenosis show variable safety and feasibility, with limited evidence and heterogeneity, highlighting the need for lesion-specific selection and cautious, individualized clinical use.